Glucuronidation of Dihydrotestosterone and <i>trans</i>-Androsterone by Recombinant UDP-Glucuronosyltransferase (UGT) 1A4: Evidence for Multiple UGT1A4 Aglycone Binding Sites
作者:Jin Zhou、Timothy S. Tracy、Rory P. Remmel
DOI:10.1124/dmd.109.028712
日期:2010.3
UDP-glucuronosyltransferase (UGT) 1A4-catalyzed glucuronidation is an important drug elimination pathway. Although atypical kinetic profiles (nonhyperbolic, non-Michaelis-Menten) of UGT1A4-catalyzed glucuronidation have been reported occasionally, systematic kinetic studies to explore the existence of multiple aglycone binding sites in UGT1A4 have not been conducted. To this end, two positional isomers, dihydrotestosterone (DHT) and trans -androsterone ( t -AND), were used as probe substrates, and their glucuronidation kinetics with HEK293-expressed UGT1A4 were evaluated both alone and in the presence of a UGT1A4 substrate [tamoxifen (TAM) or lamotrigine (LTG)]. Coincubation with TAM, a high-affinity UGT1A4 substrate, resulted in a concentration-dependent activation/inhibition effect on DHT and t -AND glucuronidation, whereas LTG, a low-affinity UGT1A4 substrate, noncompetitively inhibited both processes. The glucuronidation kinetics of TAM were then evaluated both alone and in the presence of different concentrations of DHT or t -AND. TAM displayed substrate inhibition kinetics, suggesting that TAM may have two binding sites in UGT1A4. However, the substrate inhibition kinetic profile of TAM became more hyperbolic as the DHT or t -AND concentration was increased. Various two-site kinetic models adequately explained the interactions between TAM and DHT or TAM and t -AND. In addition, the effect of TAM on LTG glucuronidation was evaluated. In contrast to the mixed effect of TAM on DHT and t -AND glucuronidation, TAM inhibited LTG glucuronidation. Our results suggest that multiple aglycone binding sites exist within UGT1A4, which may result in atypical kinetics (both homotropic and heterotropic) in a substrate-dependent fashion.
UDP-葡萄糖醛酸基转移酶(UGT)1A4催化的葡萄糖醛酸化作用是一种重要的药物消除途径。虽然 UGT1A4 催化葡萄糖醛酸化的非典型动力学特征(非双曲、非迈克尔斯-门顿)偶有报道,但尚未开展系统的动力学研究来探索 UGT1A4 中是否存在多个苷元结合位点。为此,我们使用了两种位置异构体--双氢睾酮(DHT)和反式-雄甾酮(t -AND)--作为探针底物,评估了它们与 HEK293 表达的 UGT1A4 单独和在 UGT1A4 底物[他莫昔芬(TAM)或拉莫三嗪(LTG)]存在时的葡萄糖醛酸化动力学。与高亲和力 UGT1A4 底物 TAM 共同作用会对 DHT 和 t -AND 的葡萄糖醛酸化产生浓度依赖性激活/抑制作用,而低亲和力 UGT1A4 底物 LTG 则对这两个过程产生非竞争性抑制作用。然后评估了 TAM 单独和在不同浓度的 DHT 或 t -AND 存在下的葡萄糖醛酸化动力学。TAM 显示出底物抑制动力学,表明 TAM 在 UGT1A4 中可能有两个结合位点。然而,随着 DHT 或 t -AND 浓度的增加,TAM 的底物抑制动力学曲线变得更加双曲线。各种双位点动力学模型充分解释了 TAM 与 DHT 或 TAM 与 t -AND 之间的相互作用。此外,还评估了 TAM 对 LTG 葡萄糖醛酸化的影响。与 TAM 对 DHT 和 t -AND 葡萄糖醛酸化的混合效应不同,TAM 可抑制 LTG 葡萄糖醛酸化。我们的研究结果表明,UGT1A4 中存在多个苷元结合位点,这可能会以底物依赖的方式导致非典型动力学(同向和异向)。